Business
Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology’s 74th Annual Scientific Session
CHICAGO, March 26, 2025--Cardio Diagnostics will showcase its growing portfolio of advanced cardiovascular solutions at the ACC's 74th Annual Scientific Session & Expo.
About this update from Cardio Diagnostics Holdings Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1086,"height":272,"url":"https://media.zenfs.com/en/business-wire.com/5053b9c34781c85f4c54dbf01c0d99c7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/fC_Lu_964LYPna4i3SMcKQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/5053b9c34781c85f4c54dbf01c0d99c7","width":960,"height":240},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/xCK2p3EuW6kpRza0dRawLQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxNzI7aD01NDQ7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/5053b9c34781c85f4c54dbf01c0d99c7","width":1086,"height":272}},"lazy":false},{"type":"text","content":"CHICAGO, March 26, 2025--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced its participation in the American College of Cardiology’s 74th Annual Scientific Session & Expo (ACC.25), taking place March 29-31, 2025, at McCormick Place in Chicago, IL. Cardio Diagnostics will be exhibiting at Booth #2033, showcasing its growing portfolio of advanced cardiovascular solutions, focusing on the Company’s PrecisionCHD™ test and its enhanced Actionable Clinical Intelligence (ACI™) report designed to transform how coronary heart disease (CHD) is diagnosed and managed.","length":656,"tagName":"p"},{"type":"text","content":"Cardio Diagnostics’ mission is to redefine cardiovascular care by combining epigenetics, genetics, and artificial intelligence to enable earlier detection of heart disease and more personalized patient management. Through our commitment to data-driven innovation, Cardio Diagnostics aims to prevent heart disease, improve diagnostic accuracy, and enable clinicians with actionable insights to deliver targeted, effective care.","length":426,"tagName":"p"},{"type":"text","content":"Spotlight on PrecisionCHD™ and Actionable Clinical Intelligence (ACI™)","length":70,"tagName":"p"},{"type":"text","content":"PrecisionCHD™, Cardio Diagnostics’ flagship solution, is a clinical blood test available by prescription to aid in the diagnosis and management of coronary heart disease (CHD). Unlike traditional diagnostic tools, PrecisionCHD™ is radiation-free, requires no fasting, and is performed through a simple blood...